NIH to test Pfizer’s Paxlovid, other treatments as potential long Covid therapies

There is no proven treatment for long Covid-19, which can cause a range of debilitating symptoms in millions of Americans.

from Health and Science https://ift.tt/cSk6Bg4
https://ift.tt/3gPL9Fl
https://ift.tt/xa2lnpG

We're exiting a health-care name — putting us on the hunt to buy a new stock for the portfolio

We're taking a hard look at the Bullpen and the rest of the market for new opportunities.

from Health and Science https://ift.tt/X2vz5GM
https://ift.tt/3gPL9Fl
https://ift.tt/xa2lnpG

New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why

Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September.

from Health and Science https://ift.tt/CshZzb8
https://ift.tt/ewx9zOD
https://ift.tt/TfxS6HG

Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time

The decision jeopardizes J&J's proposed $8.9 billion settlement that would stop new lawsuits over its talc baby powder and other products from being filed.

from Health and Science https://ift.tt/U8fD5lG
https://ift.tt/ewx9zOD
https://ift.tt/TfxS6HG

Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials

The data bolsters Eli Lilly's position in the budding weight loss drug market and establishes the company as a formidable competitor to Novo Nordisk.

from Health and Science https://ift.tt/K48yv93
https://ift.tt/aOiNjfm
https://ift.tt/zH4wc5Q

New bill aims to help low-income Americans with disabilities build emergency savings through a federal match

Disabled Americans face obstacles to building wealth. A new bill aims to help low-income disabled individuals save through a federal match in ABLE accounts.

from Health and Science https://ift.tt/EZV6mw0
https://ift.tt/hRSXa1N
https://ift.tt/baem2xB

AWS announces generative A.I. tool to save doctors time on paperwork

Amazon Web Services on Wednesday announced a new service for health care software providers called AWS HealthScribe.

from Health and Science https://ift.tt/JByYxTW
https://ift.tt/hRSXa1N
https://ift.tt/baem2xB

GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future sales

London-based GSK is preparing to roll out its RSV vaccine in the U.S. and European Union this fall.

from Health and Science https://ift.tt/yPA6clB
https://ift.tt/hRSXa1N
https://ift.tt/baem2xB

Weight loss drug Wegovy is from Europe — but users in the region face a long and costly wait

The hugely popular Wegovy obesity drug will be launched in Germany this month, but high costs and supply constraints threaten to weigh heavy on the rollout.

from Health and Science https://ift.tt/YRDmnaC
https://ift.tt/U4y8k1e
https://ift.tt/CtG3dxa

Why Cramer thinks this retailer is the 'ultimate trade-down play'

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

from Health and Science https://ift.tt/NyUvA7s
https://ift.tt/U4y8k1e
https://ift.tt/CtG3dxa

Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch

Biogen, in its second-quarter earnings report, said the plan will result in $700 million in net operating expense savings by 2025. 

from Health and Science https://ift.tt/gwCj49E
https://ift.tt/U4y8k1e
https://ift.tt/CtG3dxa

Biden administration aims to crack down on inadequate insurance for mental health care

Insurance plans often do not provide enough therapists in network, which requires patients to seek care out of network and pay more for their health care.

from Health and Science https://ift.tt/QwmHrav
https://ift.tt/xtpD7UO
https://ift.tt/DJl3yiz

Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer

J&J said it received a waiver that dismisses the share lockup period associated with Kenvue's initial public offering in May.

from Health and Science https://ift.tt/8av0mgs
https://ift.tt/xtpD7UO
https://ift.tt/DJl3yiz

Warning labels in the U.S. seem to be everywhere. Here's why they may be pointless

The prevalence of warning labels has been increasing on consumer products in the past several decades, but researchers aren't convinced they actually work.

from Health and Science https://ift.tt/SoHV2Ym
https://ift.tt/rj1bpCd
https://ift.tt/ziOJVBp

Pfizer says no major tornado damage to drug manufacturing areas of North Carolina facility

The pharmaceutical company did not say whether it expected the tornado damage to lead to new drug shortages for sterile injectables.

from Health and Science https://ift.tt/80iqrbv
https://ift.tt/yMoDSp7
https://ift.tt/NSpmbtO

Kenvue CEO says consumers are spending on brand-name health products even as they pull back in other areas

Thibaut Mongon's remarks follow Kenvue's second-quarter earnings beat, which was fueled by resilient demand for brands like Band-Aid, Tylenol and Aveeno.

from Health and Science https://ift.tt/qo0SXZ1
https://ift.tt/7MFshI6
https://ift.tt/2yCK94w

Here's what Jim Cramer thinks about J&J stock after a pivotal talc case verdict

J&J was ordered to pay $18.8 million after jurors in California found in favor of a 24-year-old man who claimed the company's talc products caused his cancer.

from Health and Science https://ift.tt/BDVIKb0
https://ift.tt/7MFshI6
https://ift.tt/2yCK94w

Ford's dividend quality, J&J's split-off, cost basis discipline — what we think about all these

Send your questions directly to Jim Cramer and his team of analysts at investingclubmailbag@cnbc.com.

from Health and Science https://ift.tt/J5L2XAF
https://ift.tt/7MFshI6
https://ift.tt/2yCK94w

Biden administration calls on employers to help keep people insured as millions lose Medicaid

HHS estimates that 3.8 million people who are expected to lose Medicaid are eligible for health insurance coverage through an employer.

from Health and Science https://ift.tt/ZYTJnor
https://ift.tt/7MFshI6
https://ift.tt/2yCK94w

Johnson & Johnson investors can soon swap their shares for Kenvue stock — here's what you need to know

J&J owns nearly 90% of Kenvue shares and plans to reduce its stake in the company through an exchange offer that could launch "as early as the coming days."

from Health and Science https://ift.tt/VN916W0
https://ift.tt/0VFr16e
https://ift.tt/zuwyn7L

J&J's strong quarter was amplified by new details around its big Kenvue consumer unit stake

Johnson & Johnson's management updated their thoughts on how to handle the company's 89.6% interest in Kenvue.

from Health and Science https://ift.tt/206o87h
https://ift.tt/0VFr16e
https://ift.tt/zuwyn7L

Kenvue earnings top estimates in J&J spinoff's first quarterly report since IPO

J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff’s business for the time being.

from Health and Science https://ift.tt/zIGN8EY
https://ift.tt/0VFr16e
https://ift.tt/zuwyn7L

Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge

The results come amid investor anxiety over the thousands of lawsuits claiming that J&J's talc-based baby powder and other products caused cancer.

from Health and Science https://ift.tt/KQrfgso
https://ift.tt/0VFr16e
https://ift.tt/zuwyn7L

Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results

Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.

from Health and Science https://ift.tt/uZnq4GJ
https://ift.tt/0VFr16e
https://ift.tt/zuwyn7L

Medicare proposes removing limit on PET scans used to help diagnose Alzheimer's disease

Medicare's proposal to cover PET scans for Alzheimer's would make it easier for patients to access new drugs like Leqembi.

from Health and Science https://ift.tt/dlZSLfN
https://ift.tt/J05LGqa
https://ift.tt/tl5UjER

Johnson & Johnson sues Biden administration over Medicare drug price negotiations

Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.

from Health and Science https://ift.tt/gHhuSUO
https://ift.tt/J05LGqa
https://ift.tt/tl5UjER

Novartis stock jumps after drugmaker raises full-year guidance, launches $15 billion buyback

Novartis raised its guidance and announced the buybacks as the Swiss drugmaker reported second-quarter earnings, which topped Wall Street's expectations. 

from Health and Science https://ift.tt/KAhaIVN
https://ift.tt/J05LGqa
https://ift.tt/tl5UjER

Nearly 3 million people cut from Medicaid coverage even though many might still be eligible

About 75% of the 2.7 million people who have lost Medicaid were booted from the program because they did not complete the process to renew their coverage.

from Health and Science https://ift.tt/fWsnxLr
https://ift.tt/J05LGqa
https://ift.tt/tl5UjER

FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV

RSV is the leading cause of hospitalization among children less than a year old, according to scientists.

from Health and Science https://ift.tt/ktyIJW9
https://ift.tt/nQmDGkx
https://ift.tt/fexrVkN

Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year

Eli Lilly is racing to market donanemab for Alzheimer's after Eisai and Biogen's drug for the disease, Leqembi, won FDA approval this month.

from Health and Science https://ift.tt/xOiqbGy
https://ift.tt/nQmDGkx
https://ift.tt/fexrVkN

Insurance may not cover birth control drug Opill without prescription

Women could face barriers to obtain Opill because health insurance is not currently required to cover birth control without a prescription.

from Health and Science https://ift.tt/EvHygZX
https://ift.tt/Z6nDpBy
https://ift.tt/GSB9Jz0

UnitedHealth stock jumps after earnings top estimates despite rising medical costs

The results eased investor concerns after UnitedHealth Group flagged a surge in demand for non-urgent surgeries and outpatient services last month.

from Health and Science https://ift.tt/4qbaFxv
https://ift.tt/xzaXsZV
https://ift.tt/rCazOBA

FDA says soda sweetener aspartame is safe, disagreeing with WHO finding on possible cancer link

The FDA said the studies that World Health Organization experts relied on to make this conclusion had "significant shortcomings."

from Health and Science https://ift.tt/FLTSVtc
https://ift.tt/xzaXsZV
https://ift.tt/rCazOBA

Eli Lilly to acquire obesity drug maker Versanis for $1.9 billion

The deal is Eli Lilly's latest attempt to capitalize on the weight loss industry gold rush, which was sparked by demand for Novo Nordisk's Wegovy and Ozempic.

from Health and Science https://ift.tt/qSm2xCQ
https://ift.tt/xzaXsZV
https://ift.tt/rCazOBA

WHO decision on aspartame could hurt diet soda sales or lead to new drink formulas

Coca-Cola, PepsiCo and Keurig Dr Pepper may decide to change their formulas and swap out aspartame for another sweetener.

from Health and Science https://ift.tt/zcinjoT
https://ift.tt/xzaXsZV
https://ift.tt/rCazOBA

Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says

Warren said the report shows that Congress needs to take additional steps to reduce the excessive prices of insulin from Eli Lilly, Sanofi and Novo Nordisk.

from Health and Science https://ift.tt/nJ2NGr6
https://ift.tt/xzaXsZV
https://ift.tt/rCazOBA

Biden administration to provide free Covid vaccines to uninsured Americans this fall through end of 2024

The HHS program aims to maintain broad access to Covid shots and treatments after the federal government shifts those products to the commercial market. 

from Health and Science https://ift.tt/EyLDoSH
https://ift.tt/xzaXsZV
https://ift.tt/rCazOBA

Biden administration asks Pfizer, Moderna and Novavax for 'reasonable' prices on updated Covid vaccines

Pfizer, Moderna and Novavax have not disclosed the exact pricing of their new vaccines, which will target the circulating omicron subvariant XBB.1.5. 

from Health and Science https://ift.tt/FkJn7Hl
https://ift.tt/dtUfKTw
https://ift.tt/mRPWpG5

FDA approves first over-the-counter birth control pill

Perrigo's Opill could significantly expand access to contraception, especially for younger women who often face logistical barriers to get birth control. 

from Health and Science https://ift.tt/p7ErN3W
https://ift.tt/dtUfKTw
https://ift.tt/mRPWpG5

Chamber of Commerce asks judge to block Medicare drug price negotiations before October 1

The U.S. Chamber of Commerce asked a judge to block the landmark ability of Medicare to negotiate drug prices.

from Health and Science https://ift.tt/8eKlb1s
https://ift.tt/dtUfKTw
https://ift.tt/mRPWpG5

FDA to review Schumer's concerns about YouTube stars' Prime Energy drink

The Food and Drug Administration says it will respond directly to Sen. Chuck Schumer's concerns about the caffeinated beverage.

from Health and Science https://ift.tt/yVEKBxv
https://ift.tt/dtUfKTw
https://ift.tt/mRPWpG5

Nvidia invests $50 million in biotech company Recursion for AI drug discovery

Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.

from Health and Science https://ift.tt/jX3TSp2
https://ift.tt/dtUfKTw
https://ift.tt/mRPWpG5

Whistleblower alleges Medtronic engaged in bribery scheme at veterans hospital

A recently unsealed lawsuit alleges sales reps from Medtronic, the world’s largest medical equipment company, operated a bribery scheme at a veteran hospital.

from Health and Science https://ift.tt/tVqwJN1
https://ift.tt/nVD8NTL
https://ift.tt/RGmvEbz

Illumina hit with record $476 million fine for closing Grail deal without EU approval

The European Commission last year blocked Illumina's $7.1 billion acquisition of Grail over concerns it would stifle innovation and consumer choice.

from Health and Science https://ift.tt/RqWPs10
https://ift.tt/nVD8NTL
https://ift.tt/RGmvEbz

EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs

The European Medicines Agency didn't specify which additional GLP-1 drugs are now being investigated, but it could potentially include Eli Lilly's Mounjaro.

from Health and Science https://ift.tt/B9ukxEc
https://ift.tt/nVD8NTL
https://ift.tt/RGmvEbz

Few patients continue weight loss drugs like Wegovy after a year but health costs soar for all

The analysis from Prime Therapeutics highlights the hefty price tag of Wegovy and other weight loss and diabetes medicines, which are also known as GLP-1s.

from Health and Science https://ift.tt/disaqjp
https://ift.tt/nVD8NTL
https://ift.tt/RGmvEbz

White House unveils plan to eliminate threat of fentanyl laced with xylazine

The Biden administration declared the dangerous illegal drug cocktail an “emerging threat” in April for its role in fueling a wave of overdose deaths.

from Health and Science https://ift.tt/TsRatjN
https://ift.tt/MrVgaxd
https://ift.tt/S4rIYjz

Novavax stock spikes 20% after company snags $350 million from Canada for unused Covid shots

Canada's Covid shot settlement is a sign of hope for investors after Novavax raised doubts about its ability to stay in business earlier this year. 

from Health and Science https://ift.tt/YjoTpCv
https://ift.tt/MrVgaxd
https://ift.tt/S4rIYjz

Sales of Alzheimers drug Leqembi may be slow initially but could pick up in 2024

Analysts believe the Medicare registry requirement and new guidance on Leqembi's prescription label could potentially weigh on sales in the near term.

from Health and Science https://ift.tt/NbZ1xVm
https://ift.tt/Kotnp9J
https://ift.tt/etPodQj

U.S. officials say risk of locally acquired malaria remains low as nationwide cases jump to seven

The CDC and health experts say the new locally acquired cases in Florida and Texas shouldn't warrant panic about widespread malaria transmission in the U.S.

from Health and Science https://ift.tt/cXWyYsf
https://ift.tt/Kotnp9J
https://ift.tt/etPodQj

FDA approves Alzheimers drug Leqembi paving way for broader Medicare coverage

Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding.

from Health and Science https://ift.tt/RzJIZud
https://ift.tt/Kotnp9J
https://ift.tt/etPodQj

Bill Ackman explains why he embraced RFK Jr.'s skepticism on Covid vaccines

Bill Ackman once criticized Covid vaccination efforts for not moving fast enough. Now he's echoing Robert F. Kennedy Jr.'s scientifically dubious skepticism.

from Health and Science https://ift.tt/FGsUxL6
https://ift.tt/dfge1FO
https://ift.tt/Xo2gCcb

Moderna strikes deal to develop mRNA drugs in China

The deal is the biotech company's first agreement with China after the Asian nation repeatedly refused to accept mRNA vaccines from U.S.-based manufacturers.

from Health and Science https://ift.tt/eywNscW
https://ift.tt/dfge1FO
https://ift.tt/Xo2gCcb